SiRNA-mediated silencing of ERK3 expression in non-small cell lung cancer (NSCLC) cell lines A549 and H1299 decreased migration and invasion, while expression of exogenous ERK3 led to increased motility (Long et al., 2012; Elkhadragy et al., 2018). This evidence concerns the gene MAPK6 and non-small cell lung carcinoma.